Home >
Access the latest news, business developments, company updates, industry trends, events and more.
A clinical-stage nonprofit biotechnology company, Cure Rare Disease, has acquired its first laboratory space in Woodbridge. The organization will relocate its Boston headquarters to the 30,000-square-foot...
Enrich Therapeutics reports that the company had been awarded a 12-month Small Business Innovation Research (SBIR) research contract from the National Cancer Institute. The contract is...
View this email in your browser Career News – October 4, 2022 BioCT company members have access to MassBioEd’s professional training courses at a discounted member rate....
Cara Therapeutics reports that its licensing partner Maruishi Pharmaceutical has submitted a New Drug Application in Japan for approval of difelikefalin (KORSUVA®) for the treatment of pruritus...
BioCT invites nominations for this year’s Entrepreneur of the Year Award. Established by BioCT and Shipman & Goodwin, the Entrepreneur of the Year Award acknowledges the importance of showcasing the unique accomplishments...
TELEEO solves the world’s greatest challenges through world-class product development, engineering, manufacturing, and consulting. TELEEO delivers solutions that drive business outcomes in the Life Science and...
The UConn Board of Trustees has appointed Radenka Maric UConn’s 17th president. Maric is a longtime UConn employee who was vice president for research, innovation and entrepreneurship. Maric...
Danforth Advisors helps life science companies start, grow, and operate at their best. They match world-class R&D with the same caliber of expertise in the areas...
New Haven’s newest life sciences building, Elm City Bioscience Center, was recently unveiled in a ribbon cutting ceremony and celebration. The Hurley Group, owner, developer, and manager...
LabDIRECT is a supplier and manufacturer of common and specialty chemical and reagents for laboratory, research, education, and industrial applications. Their goal is to streamline affordability and access...